Page last updated: 2024-08-22

sizofiran and Carcinoma, Hepatocellular

sizofiran has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Itoh, H; Kitajima, M; Seki, M; Tachikawa, I; Watanabe, Y; Yagita, A	1

Other Studies

1 other study(ies) available for sizofiran and Carcinoma, Hepatocellular

Article	Year
[A long-term survivor of primary hepatoma--a case suggesting the superiority of a multi-drug (OK-432, SPG, PSK) over mono-drug immunotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Mitomycin; Mitomycins; Picibanil; Prognosis; Proteoglycans; Sizofiran	1986

Article

Year

[A long-term survivor of primary hepatoma--a case suggesting the superiority of a multi-drug (OK-432, SPG, PSK) over mono-drug immunotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:5

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Mitomycin; Mitomycins; Picibanil; Prognosis; Proteoglycans; Sizofiran

1986